6-4 PP |
6–4 photoproduct |
aa |
amino acid |
AML |
acute myeloblastic leukaemia |
APIM |
AlkB homolog 2 PCNA interacting motif |
Arg |
arginine |
Asn |
asparagine |
Asp |
aspartic acid |
ATM |
Ataxia telangiectasia mutated protein kinase |
ATR |
Ataxia telangiectasia and Rad3-related kinase |
ATRIP |
ATR interacting protein |
BC |
breast cancer |
BMAL1 |
brain and muscle ARNT-like protein 1 |
CDDP |
cisplatin |
CEN2 |
centrin 2/caltractin 1 |
CEP164 |
centrosomal protein 164 |
CHK1 |
cell cycle checkpoint kinase 1 |
CHK2 |
cell cycle checkpoint kinase 2 |
CHMP1A |
charged multivesicular body protein 1A |
CLEC4M |
C-type lectin domain family 4 member M |
CLOCK |
circadian locomotor output cycles kaput |
CRC |
colorectal cancer |
CSA |
Cockayne syndrome group A |
CSB |
Cockayne syndrome group B |
CPD |
cyclobutane pyrimidine dimer |
Cys |
cysteine |
DDB |
damaged DNA-binding protein |
DDR |
DNA damage response |
DSB |
DNA double-strand break |
dsDNA |
double-stranded DNA |
ERCC1 |
excision repair cross-complementation group 1 |
ESCC |
esophageal squamous cell carcinoma |
GC |
gastric cancer |
GENT |
Gene Expression Database of Normal and Tumor Tissues |
GG-NER |
global-genome nucleotide excision repair |
Gln |
glutamine |
Gly |
glycine |
GRASP65 |
Golgi reassembly stacking protein of 65 kDa |
HERC2 |
HECT and RCC1-like domain containing E3 ubiquitin protein ligase 2 |
HIF-1α |
hypoxia-inducible factor 1 alpha |
His |
histidine |
HMGA |
non-histone high-mobility group A |
HNSCC |
head and neck squamous cell carcinoma |
HR23B |
human homologue of yeast Rad23 protein |
HRE |
hypoxia response element |
IGCCCG |
International Germ Cell Cancer Collaborative Group |
Ile |
isoleucine |
LC |
lung cancer |
Leu |
leucine |
MBD |
minimal DNA binding domain |
NAC |
neoadjuvant chemotherapy |
NER |
nucleotide excision repair |
NERI01 |
NER inhibitor 01 |
NLS |
nuclear localization signal |
NMR |
nuclear magnetic resonance |
NPC |
nasopharyngeal carcinoma |
OC |
ovarian cancer |
OS |
overall survival |
OSCC |
oral squamous cell carcinoma |
PARP1 |
poly(ADP-ribose) polymerase 1 |
PARylation |
poly(ADP-ribosyl)ation |
PCNA |
proliferating cell nuclear antigen |
PER1 |
period circadian protein homolog 1 |
Phe |
phenylalanine |
PRECOG |
Prediction of Clinical Outcomes from Genomic Profiles |
Pro |
proline |
PTM |
post-translational modification |
RC |
rectal cancer |
RNAPII |
RNA polymerase II |
RASSF1A |
Ras-association domain family 1A |
RPA |
replication protein A |
SCC |
squamous cell carcinoma |
Ser |
serine |
SIRT1 |
silent mating type information regulation 2 homologue 1 |
SNP |
single nucleotide polymorphism |
ssDNA |
single-stranded DNA |
TCGA |
The Cancer Genome Atlas |
TC-NER |
transcription-coupled nucleotide excision repair |
TFIIH |
transcription factor IIH |
TGCT |
testicular germ cell tumour |
TGFβ |
transforming growth factor beta |
TNM |
tumour node metastasis |
TTDA |
Trichothiodystrophy group A |
Tyr |
tyrosine |
UCC |
uterine cervical cancer |
UTR |
untranslated region |
UV |
ultraviolet |
UV-DDB |
UV-damaged DNA-binding protein |
WIP1 |
wild-type p53-induced phosphatase 1 |
XAB(1-5) |
XPA-binding protein 1-5 |
XPA |
Xeroderma Pigmentosum group A |
XPB |
Xeroderma Pigmentosum group B |
XPC |
Xeroderma Pigmentosum group C |
XPD |
Xeroderma Pigmentosum group D |
XPE |
Xeroderma Pigmentosum group E |
XPF |
Xeroderma Pigmentosum group F |
XPG |
Xeroderma Pigmentosum group G |